EXICURE, INC. Stock Issued During Period, Shares, Employee Stock Purchase Plans
EXICURE, INC. (XCUR) had Stock Issued During Period, Shares, Employee Stock Purchase Plans of 103.10 thousand shares as of 2021-05-14, per its 10-Q filed 2021-08-12.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans · last filed 2021-08-12
- 2021-05-14: Stock Issued During Period, Shares, Employee Stock Purchase Plans 103.10K shares.
| Period end | Stock Issued During Period, Shares, Employee Stock Purchase Plans |
|---|---|
| 2021-05-14 | 103.10K shares 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |